Why the study?
Does the automatic implantable defibrillator safely and effectively terminate malignant arrhythmias in survivors of refractory cardiac arrest?
Population
16 survivors of multiple cardiac arrests refractory to antiarrhythmic therapy
Design
Case_series
Authors
Loading...
Supports feasibility in refractory arrest survivors; leaves open need for larger trials before broader adoption.
Does the automatic implantable defibrillator safely and effectively terminate malignant arrhythmias in survivors of refractory cardiac arrest?
Early clinical experience demonstrates that the automatic implantable defibrillator can successfully recognize and terminate malignant ventricular arrhythmias in high-risk patients.
Mirowski et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: